EP0343950A3

Human fc-gamma receptor iii

Abstract

Soluble and membrane-bound forms of human FcγRIII are provided, together with nucleic acids capable of encoding the same. Soluble FcγRIIIs are useful in ameliorating the serum platelet deficiency associated with immune thrombocytopenic purpura. Cells expressing membrane-bound FcγRIII are useful components in assays for serum immune complexes.

Term

Term ended

Projected expiry passed 24 May 2009, 17.3 years ago.

Every citation, both ways

Citations
Document	Relation	Office	Category	Cited during
WO8707277A1	Cites	World Intellectual Property Organization (WIPO)	A	Search report

30 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims8

Priority claims
Document	Office	Kind	Date
199513	United States of America	–	1988-05-27
19951388	United States of America	A	1988-05-27
19951388	United States of America	A	1988-05-27
300039	United States of America	–	1989-01-19
30003989	United States of America	A	1989-01-19
30003989	United States of America	A	1989-01-19
US19880199513	–	–	–
US19890300039	–	–	–

Members30

Family members, oldest first
Document	Office	Kind
EP0343950A2	European Patent Office (EPO)	A2	1989-11-29
WO8911490A1	World Intellectual Property Organization (WIPO)	A1	1989-11-30
AU3740089A	Australia	A	1989-12-12
CA2000355A1	Canada	A1	1990-07-19
KR900701843A	Republic of Korea	A	1990-12-04
JPH03501484A	Japan	A	1991-04-04
EP0343950A3This record	European Patent Office (EPO)	A3	1991-07-10
EP0449828A1	European Patent Office (EPO)	A1	1991-10-09
EP0791653A1	European Patent Office (EPO)	A1	1997-08-27
JP2657221B2	Japan	B2	1997-09-24
US5767077A	United States of America	A	1998-06-16
HK1001403A1	Hong Kong, China	A1	1998-06-19
KR0149012B1	Republic of Korea	B1	1998-08-17
US5976831A	United States of America	A	1999-11-02
EP0343950B1	European Patent Office (EPO)	B1	2000-10-18
AT197053T	Austria	T	2000-11-15
ATE197053T1	Austria	T1	2000-11-15
DE68929256D1	Germany	D1	2000-11-23
ES2150898T3	Spain	T3	2000-12-16
GR3034698T3	Greece	T3	2001-01-31
DE68929256T2	Germany	T2	2001-05-17
US6294347B1	United States of America	B1	2001-09-25
EP0791653B1	European Patent Office (EPO)	B1	2006-03-22
AT321134T	Austria	T	2006-04-15
ATE321134T1	Austria	T1	2006-04-15
DE68929546D1	Germany	D1	2006-05-11
EP0791653B9	European Patent Office (EPO)	B9	2006-08-30
DE68929546T2	Germany	T2	2006-09-21
ES2262163T3	Spain	T3	2006-11-16
DE68929546T4	Germany	T4	2007-03-08

54 legal events, as 5 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2010-04-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2009-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2009-10-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2009-08-03	Nl: ceased due to reaching the maximum lifetime of a patentCeasedNLV7	NLV7	EP
2009-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2009-07-28	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2009-07-14	Se: european patent has lapsedLapsedEUG	EUG	EP
2009-06-17	Patent expired after termination of 20 yearsExpiredPE20	PE20	GB
2009-05-31	Be: patent expiredExpiredBE20	BE20	EP
2009-05-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2009-05-29	Patent ceasedCeasedPL	PL	CH
2009-03-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-12-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-09-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-08-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-08-29	Transmission of propertyTP	TP	FR
2008-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2007-12-12	Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E	732E	GB
2007-12-03	Nl: assignments of ep-patentsNLS	NLS	EP
2007-10-15	AssignmentPUE	PUE	CH
2007-09-28	Change of the address of the representativeISLER & PEDRAZZINI AG;POSTFACH 1772;8027 ZUERICH (CH)PCAR	PCAR	CH
2002-01-01	European patent in force as of 2002-01-01IF02	IF02	GB
2001-10-04	No opposition filedOpposition26N	26N	EP
2001-08-17	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2001-08-17	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2001-02-09	Fr: translation filedET	ET	EP
2001-01-15	New agentNV	NV	CH
2000-12-16	Definitive protectionFG2A	FG2A	ES
2000-11-23	Corresponds to:REF	REF	EP
2000-10-31	European patent takes effect as a national patent in ch/liEP	EP	CH
2000-10-20	It: translation for a ep patent filedITF	ITF	EP
2000-10-20	It: translation for a ep patent filedITF	ITF	EP
2000-10-18	Designated contracting statesAK	AK	EP
2000-10-18	Corresponds to:REF	REF	EP
2000-10-18	Miscellaneous (additional remarks)VERBUNDEN MIT 89906578.3/0449828 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 20.10.93.XX	XX	EP
2000-09-01	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2000-06-21	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH	GRAH	EP
2000-04-20	Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG	GRAG	EP
2000-04-20	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH	GRAH	EP
2000-04-19	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
1997-11-05	Party data changed (applicant data changed or rights of an application transferred)RAP3	RAP3	EP
1997-09-17	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
1993-12-08	Miscellaneous (additional remarks)VERBUNDEN MIT 89906578.3/0449828 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 20.10.93.XX	XX	EP
1992-12-16	First examination report despatched17Q	17Q	EP
1991-10-23	Request for examination filed17P	17P	EP
1991-07-10	Designated contracting statesAK	AK	EP
1991-05-23	Search report despatchedORIGINAL CODE: 0009013PUAL	PUAL	EP
1989-11-29	Designated contracting statesAK	AK	EP
1989-10-14	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Human fc-gamma receptor iii

Abstract

Term

Priority claims8

Members30

Over the term

Events

Numbers

Titles3

Classification

Designated states13